# Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)

Study · id `cardio:ct-nct05472012` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05472012](<https://clinicaltrials.gov/study/NCT05472012>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05472012

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.

## Technical summary

Registry record NCT05472012. Allocation not applicable; no masking; primary purpose other. Start 2022-07-25 (actual); primary completion 2023-12-16 (actual). Results posted on 2025-05-22.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 139 participants (enrolled count; ClinicalTrials.gov record NCT05472012, source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)
- Started: 2022-07-25 (actual) (ClinicalTrials.gov record NCT05472012, source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)
- Primary completion: 2023-12-16 (actual) (ClinicalTrials.gov record NCT05472012, source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)
- Completion: 2023-12-16 (actual) (ClinicalTrials.gov record NCT05472012, source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)
- Results first posted: 2025-05-22 (ClinicalTrials.gov record NCT05472012, source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05472012, source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05472012-2025-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)
- Condition: Atrial Fibrillation
- Intervention (Device): INVSENSOR00057
- Lead sponsor: Masimo Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Masimo Corporation (`cardio:org-masimo-corporation`)

## Provenance

Content hash: b27470ef27f2b489c7b6fb706d307465a459e39a805008f6f6debf1f94b90052
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
